NewAmsterdam Pharma Company N.V.

NAMSW proxies request shareholder approval for 2025 accounts and structure

# 📜 What This Document Is 📄 This document is a Preliminary Proxy Statement (PRE 14A). Think of it as the comprehensive instruction manual for the company's upcoming annual shareholder meeting. It's *not* an earnings report; instead, it outlines what the company is asking you, the shareholder, to v